Michigan Rx rebate requirements upheld
Executive Summary
Michigan Medicaid may require prior authorization for drugs that do not provide rebates to non-Medicaid programs, D.C. federal appeals court affirms April 2. The Pharmaceutical Research & Manufacturers of America's lawsuit against the state argued the policy was not in the "best interest" of Medicaid recipients; the lower court also ruled against PhRMA (1"The Pink Sheet" March 31, 2003, In Brief). The 2appellate court ruling cited the Supreme Court's rejection of PhRMA's challenge to a similar Maine program last year (3"The Pink Sheet" May 26, 2003, p. 23). [Editor's Note: A version of this story first appeared in 4"The Pink Sheet" DAILY April 2. Visit our website, www.ThePinkSheetDAILY.com, to sign up for a free trial.]...
You may also be interested in...
Supreme Court Allows Maine Rx; PhRMA Says States Will Delay Similar Plans
The Pharmaceutical Research & Manufacturers of America believes that until Maine issues regulations to implement Maine Rx, other states will wait before proceeding with similar programs
PhRMA v. HHS
Michigan Medicaid supplemental rebate program upheld by D.C. federal court March 28. The court heard oral arguments on the Pharmaceutical Research & Manufacturers of America's challenge of the program Aug. 28, 2002 and Feb. 5 (1"The Pink Sheet" Feb. 10, p. 16)...
MoCRA Stakeholders Reminded Registration Enforcement Begins 1 July: ‘Do Not Delay!’
The Independent Beauty Association urged stakeholders at its Cosmetic Convergence Symposium to take action to ensure they are meeting requirements of the Modernization of Cosmetics Regulation Act come 1 July, when FDA’s enforcement of the facility and product registration deadline begins. Presenters offered tips from companies that have already completed the process.